Free Trial
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

$74.34
-0.74 (-0.99%)
(As of 09/6/2024 ET)
Today's Range
$74.22
$75.47
50-Day Range
$65.26
$75.50
52-Week Range
$56.34
$75.80
Volume
264,176 shs
Average Volume
248,488 shs
Market Capitalization
$3.69 billion
P/E Ratio
17.83
Dividend Yield
N/A
Price Target
$98.75

Prestige Consumer Healthcare MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
32.8% Upside
$98.75 Price Target
Short Interest
Healthy
3.70% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
0.26mentions of Prestige Consumer Healthcare in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.24%
From $4.42 to $4.74 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.78 out of 5 stars

Medical Sector

69th out of 910 stocks

Pharmaceutical Preparations Industry

26th out of 426 stocks

PBH stock logo

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

PBH Stock Price History

PBH Stock News Headlines

"Doomsday indicator” flashing for the first time since the Great Depression...
It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...
"Doomsday indicator” flashing for the first time since the Great Depression...
It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...
Prestige Consumer Q4 Earnings Miss, Operating Margin Falls
See More Headlines
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2024
Today
9/07/2024
Next Earnings (Estimated)
11/07/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
CUSIP
74112D10
Employees
540
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$98.75
High Stock Price Target
$117.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+32.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$209.34 million
Pretax Margin
23.87%

Debt

Sales & Book Value

Annual Sales
$1.13 billion
Cash Flow
$4.96 per share
Book Value
$33.34 per share

Miscellaneous

Free Float
48,880,000
Market Cap
$3.68 billion
Optionable
Optionable
Beta
0.48
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

PBH Stock Analysis - Frequently Asked Questions

How have PBH shares performed this year?

Prestige Consumer Healthcare's stock was trading at $61.22 at the beginning of the year. Since then, PBH shares have increased by 21.4% and is now trading at $74.34.
View the best growth stocks for 2024 here
.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its quarterly earnings data on Thursday, August, 8th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.04. The business's revenue was down 4.4% on a year-over-year basis.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Prestige Consumer Healthcare's major shareholders?

Top institutional investors of Prestige Consumer Healthcare include Dimensional Fund Advisors LP (6.05%), Ariel Investments LLC (5.72%), Victory Capital Management Inc. (4.18%) and Allspring Global Investments Holdings LLC (2.66%). Insiders that own company stock include Ronald M Lombardi and Mary Beth Fritz.
View institutional ownership trends
.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE) and Wells Fargo & Company (WFC).

This page (NYSE:PBH) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners